Because of its high-acuity patient population and intensive resource requirements, TAVR is often seen as an economically unsustainable procedure option. To address these concerns, Baylor Scott and White Health’s (BSWH’s) leadership explored the broader financial impact of TAVR to uncover the hidden value beyond the procedure itself. By exploring the broader advantages, BSWH shifted the narrative surrounding TAVR from loss to strategic growth. This webinar discusses their approach and lessons learned, emphasizing collaboration, data governance and iterative improvement as part of BSWH’s roadmap for success.

Mohamed Safa, MSc, System Director, Strategic Advanced Analytics, Baylor Scott and White Health
Trey Wicke, CHFP, Chief Financial Officer, Baylor Scott and White Health

Moderators:
Katie Willerick, Director of Data Analytics, MedAxiom
Denise Busman, Vice President, Care Transformation, MedAxiom